Skip to Main Content

Try STAT+ TODAY

The Regulars

Most Read

Gut Check Sharon Begley

Can curcumin spice treat Alzheimer’s disease?

Pharmalot Ed Silverman

STAT Plus: J&J loses a patent battle in India over a crucial tuberculosis drug

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA panel backs conditional approval for Biogen ALS drug; pharma fights tactic for lowering specialty med costs

Pharmalot Ed Silverman

Drugmakers push back on a clever tactic employers use to avoid paying for specialty medicines

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: U.K. regulator to streamline clinical trial approvals; NIH won’t seize patents to cut price of cancer drug

Pharmalot Ed Silverman

STAT Plus: NIH rejects bid to cut a cancer drug’s price by sidestepping patents

Pharmalot Ed Silverman

STAT Plus: Patient groups balk at former AstraZeneca official negotiating U.K.-India free trade deal

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA official wants to use accelerated approval for gene therapies; pharma asks Biden for tax breaks in the semiconductor package

All Coverage

Pharmalot Ed Silverman

STAT Plus: Sanofi becomes the third leading insulin maker to lower list prices, cutting Lantus price by 78%

Pharmalot Ed Silverman

STAT Plus: Here’s why there aren’t many cheap, generic versions of pricey inhalers

advertisement

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Alzheimer’s group starts lobbying for Medicare to cover new drug; U.S. judge seems sympathetic to abortion-pill challenge

Pharmalot Ed Silverman

STAT Plus: U.K. trade group suspends Novo Nordisk for ‘serious breaches’ in promoting obesity drug

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biden administration to fine drugmakers for price hikes on 27 meds; Dems push pharmacy chains over access to abortion pill

Pharmalot Ed Silverman

STAT Plus: Democratic lawmakers press pharmacy chains on abortion pill access

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Novo to cut some insulin prices by up to 75%; Veterans Administration to cover new Alzheimer’s treatment

Pharmalot Ed Silverman

STAT Plus: Novo Nordisk to lower insulin prices by up to 75% amid growing pressure

Pharmalot Ed Silverman

STAT Plus: Veterans Health Administration will cover the newest Alzheimer’s drug

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biogen exec who quarterbacked Aduhelm leaves; Pfizer to buy Seagen for $43 billion

Pharmalot Ed Silverman

STAT Plus: Up and down the ladder: The latest comings and goings

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: New York officials press pharmacy chains over abortion pill; Sanders pushes bill for $20 insulin cap

Pharmalot Ed Silverman

STAT Plus: Insulin for $20 a vial? Sanders pushes bill for price caps on the diabetes treatment

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Pharmacies are battlegrounds in the abortion debate; Lilly Alzheimer’s drug failed to prevent memory loss in study

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: FDA head wants to get rid of advisory panel votes; premature-birth drug is finally withdrawn

Pharmalot Ed Silverman

STAT Plus: Controversial drug for premature birth is withdrawn by manufacturer after battle with FDA

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Biden proposes expanding Medicare drug-price negotiation; Weight Watchers moves into obesity drug market

Pharmalot Ed Silverman

STAT Plus: Pharmalittle: Walgreens won’t dispense abortion pills in several states; Lilly avoids paying Medicaid rebates with insulin price cuts